Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM4 | O15151 | 3/20 | 0.55 |
| ▸ | TP53 | P04637 | 3/20 | 0.55 |
| ▸ | SLC17A5 | Q9NRA2 | 1/20 | 0.51 |
| ▸ | CASP3 | P42574 | 2/20 | 0.48 |
| ▸ | MDM2 | Q00987 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | TLR2 | O60603 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29503847 | 1.00 | MDM4 (0.55) | MDM4TP53SLC17A5CASP3MDM2 | |
| SCHEMBL3436122 | 1.00 | MDM4 (0.55) | MDM4TP53SLC17A5CASP3MDM2 | |
| SCHEMBL29560536 | 1.00 | MDM4 (0.55) | MDM4TP53SLC17A5CASP3MDM2 | |
| SCHEMBL5998507 | 1.00 | MDM4 (0.55) | MDM4TP53SLC17A5CASP3MDM2 | |
| SCHEMBL29395463 | 1.00 | MDM4 (0.55) | MDM4TP53SLC17A5CASP3MDM2 | |
| SCHEMBL29400438 | 0.94 | MDM2 (0.52) | MDM4TP53SLC17A5CASP3MDM2 | |
| SCHEMBL28335917 | 0.94 | MDM2 (0.52) | MDM4TP53SLC17A5CASP3MDM2 | |
| SCHEMBL3212833 | 0.92 | MDM4 (0.52) | MDM4TP53SLC17A5CASP3MDM2 | |
| SCHEMBL29047058 | 0.92 | MDM4 (0.49) | MDM4TP53SLC17A5CASP3MDM2 | |
| SCHEMBL12744189 | 0.92 | MDM4 (0.52) | MDM4TP53SLC17A5CASP3MDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1957 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026103789-A1 | METHOD FOR PREPARING LUTETIUM[177LU]DOTATATE AND PRECURSOR COMPOUND THEREOF | 迈得诺医疗科技集团有限公司 | 2026-05-21 | — | — | WO | claimed |
| US-20260115268-A1 | Heat-Stable Enterotoxins Mutants as Antidiarrheal Vaccine Antigens | VESTLANDETS INNOVASJONSSELSKAP AS (NO) | 2026-04-30 | — | — | US | claimed |
| US-12527853-B2 | Heat-stable enterotoxins mutants as antidiarrheal vaccine antigens | VESTLANDETS INNOVASJONSSELSKAP AS (VIS) (NO) | 2026-01-20 | — | — | US | claimed |
| US-20250332299-A1 | COMPOUND TARGETING SSTR2, PREPARATION METHOD THEREFOR AND USE THEREOF | YANTAI LANNACHENG BIOTECHNOLOGY CO LTD (CN) | 2025-10-30 | — | — | US | claimed |
| EP-4613758-A1 | COMPOUNDS TARGETING SSTR2, PREPARATION METHOD THEREFOR, AND USE THEREOF | Yantai Lannacheng Biotechnology Co., Ltd. (CN) | 2025-09-10 | — | — | EP | claimed |
| EP-4602368-A1 | NITRILOTRIACETIC ACID LINKERS, SOLID PHASE SYNTHESIS OF NITRILOTRIACETIC ACID LINKERS AND APPLICATIONS THEREOF | Nicoya Lifesciences Inc. (CA) | 2025-08-20 | — | — | EP | claimed |
| EP-4448545-B1 | MANUFACTURING PROCESS FOR THE PRODUCTION OF LINACLOTIDE | CHEMI SPA (IT) | 2025-08-20 | — | — | EP | claimed |
| CN-118994311-B | Preparation method of decapeptide-4, composition for preventing alopecia and hair product prepared from decapeptide-4 compound plant extract | 南京斯拜科生物科技股份有限公司 | 2025-06-17 | — | — | CN | claimed |
| CN-115215925-B | Somatostatin type 2 receptor inhibitor, radionuclide complex thereof, preparation method and application | 上海益泰医药科技有限公司 | 2025-06-17 | — | — | CN | claimed |
| CN-120136972-A | Novel Urantide polypeptide synthesis process | 湖北强耀生物科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-112094324-B | Synthesis method of carbetocin | 宁波三生生物科技股份有限公司 | 2022-05-03 | — | — | CN | claimed |
| CN-114380902-A | Preparation method of HGH (176- | 江苏诺泰澳赛诺生物制药股份有限公司 | 2022-04-22 | — | — | CN | claimed |
| CN-111499719-B | Method for synthesizing pramlintide | 杭州固拓生物科技有限公司 | 2022-04-08 | — | — | CN | claimed |
| CN-113956333-B | Synthesis and purification method of linaclotide | 浙江湃肽生物有限公司南京分公司 | 2022-03-29 | — | — | CN | claimed |
| CN-114249808-A | Synthesis method of Cagrilintide | 杭州诺泰澳赛诺医药技术开发有限公司 | 2022-03-29 | — | — | CN | claimed |
| CN-109678927-B | Glutathione total synthesis method based on phosphate carrier | 西北工业大学 | 2022-03-15 | — | — | CN | claimed |
| CN-114057862-A | Synthetic method of GLP-1(1-37) polypeptide | 安徽省国平药业有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-109180803-B | Somatostatin and preparation method and pharmaceutical composition thereof | 成都天台山制药有限公司 | 2022-02-08 | — | — | CN | claimed |
| CN-104744327-B | A kind of compound and preparation method thereof and utilize its method preparing polypeptide | 中国科学院合肥物质科学研究院 | 2016-08-24 | — | — | CN | claimed |
| CN-104744327-A | Compound, preparation method thereof and method for preparing polypeptide by virtue of compound | HEFEI INST PHYSICAL SCI CAS | 2015-07-01 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115268-A1 | Heat-Stable Enterotoxins Mutants as Antidiarrheal Vaccine Antigens | SCN8A, SCN9A, VIP | MDM4 4004/4885TP53 571/4885SLC17A5 1474/4885 |
| US-20250332299-A1 | COMPOUND TARGETING SSTR2, PREPARATION METHOD THEREFOR AND USE THEREOF | SSTR2, SSTR5, SSTR3 | MDM4 4630/4885TP53 2881/4885SLC17A5 215/4885 |
| US-12527853-B2 | Heat-stable enterotoxins mutants as antidiarrheal vaccine antigens | VIP, MLEC, SEC16A | MDM4 2800/4885TP53 1413/4885SLC17A5 3568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.